These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 13959698)

  • 21. [Effect of adjuvant hormonotherapy on the results of the radiation treatment of patients with cancer of the corpus uteri].
    Bokhman IaV; Stoliarova IV; Gastev AIu
    Vopr Onkol; 1987; 33(4):49-52. PubMed ID: 3296435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
    Kline RC; Freedman RS; Jones LA; Atkinson EN
    Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
    [No Abstract]   [Full Text] [Related]  

  • 23. Massive-dose progestational therapy in oncology (medroxyprogesterone). Preliminary results.
    Pannuti F; Martoni A; Pollutri E; Camera P; Losinno F; Giusti H
    Panminerva Med; 1976; 18(3-4):129-36. PubMed ID: 176620
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of hepatic function and carbohydrate metabolism during therapy with 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate in adenocarcinoma of the uterine body. I. Influence on the electrophoretic protein pattern, and serum transaminases and alkaline phosphatase].
    Lanza A
    Minerva Ginecol; 1969 Dec; 21(23):1612-23. PubMed ID: 5373230
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medroxyprogesterone acetate treatment of a case of hyperadrenalism with adenocarcinoma of the endometrium].
    Lanza A; Fedele M; Di Gregorio A; Gagna G
    Minerva Ginecol; 1980 Apr; 32(4):259-66. PubMed ID: 7383431
    [No Abstract]   [Full Text] [Related]  

  • 26. Endolymphatic stromal myosis with pulmonary metastases. Remission with progestin therapy: report of a case.
    Krumholz BA; Lobovsky FY; Halitsky V
    J Reprod Med; 1973 Feb; 10(2):85-9. PubMed ID: 4697437
    [No Abstract]   [Full Text] [Related]  

  • 27. The treatment of uterine adenocarcinoma with medroxyprogesterone acetate.
    Horger EO; Williamson HO; Hester LL
    J S C Med Assoc; 1966 Jun; 62(6):217-23. PubMed ID: 5227728
    [No Abstract]   [Full Text] [Related]  

  • 28. Turner's syndrome with endometrial adenocarcinoma and stilbestrol therapy.
    Wilkinson EJ; Friedrich EG; Mattingly RF; Regali JA; Garancis JC
    Obstet Gynecol; 1973 Aug; 42(2):193-200. PubMed ID: 4721406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S
    Minerva Ginecol; 1979; 31(7-8):597-603. PubMed ID: 481819
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diverse action of 17-alpha-hydroxyprogesterone caproate and medroxyprogesterone acetate on the biosynthesis of collagen and cirrhogenous course of CC14-induced hepatic lesions in rats].
    Gambella GR; Burlando F; Vascotto E; Novelli A
    Arch Sci Med (Torino); 1983; 140(4):413-6. PubMed ID: 6231903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Medroxyprogesterone and endometrial adenocarcinoma].
    Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
    [No Abstract]   [Full Text] [Related]  

  • 32. A PROGESTATIONAL AGENT (MEDROXYPROGESTERONE ACETATE) IN TREATMENT OF PRIMARY ADENOCARCINOMA OF THE CERVIX. REPORT OF A CASE.
    MADDEN EP
    Obstet Gynecol; 1964 Mar; 23():409-12. PubMed ID: 14128471
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
    Cohen CJ; Deppe G; Bruckner HW
    Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of progestational agents in the management of metastatic carcinoma of the endometrium.
    Kistner RW; Griffiths CT
    Clin Obstet Gynecol; 1968 Jun; 11(2):439-56. PubMed ID: 4879374
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
    Okada H; Nakata Y; Fujimoto J; Fujita H
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2837-44. PubMed ID: 2959204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment].
    Shenderëva TS; Shvedova LA
    Vopr Onkol; 1981; 27(10):52-6. PubMed ID: 7303557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report.
    Piver MS; Lele S; Barlow JJ
    Obstet Gynecol; 1980 Sep; 56(3):370-2. PubMed ID: 7422177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the therapy of metastases of uterine adenocarcinoma].
    Poggi G
    Minerva Ginecol; 1969 Sep; 21(18):1189-92. PubMed ID: 5402128
    [No Abstract]   [Full Text] [Related]  

  • 39. [Adjuvant gestagen therapy in stage I endometrial cancer].
    Lahousen M; Pickel H
    Zentralbl Gynakol; 1988; 110(16):1013-7. PubMed ID: 2973195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of adenocarcinomas of the uterine body with medroxyprogesterone].
    Bonte J; Drochmans A; Lassance M
    Gynecol Obstet (Paris); 1966; 65(2):179-85. PubMed ID: 5942790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.